Create
Query
event_store.db
—
signals
actions
agent_runs
approvals
artifacts
commitments
constraints
conversation_compaction
conversation_state
conversation_turns
dead_letters
decisions
deliveries
effects
email_messages
email_reply_drafts
email_threads
entities
entity_aliases
entity_tags
episode_context_index
episodes
event_subjects
events
events_archive
fact_sources
facts
inbox_items
inbox_links
intel_memory
jobs
leader_leases
links
memory_candidates
memory_embeddings
memory_items
memory_items_fts
(v)
memory_items_fts_config
memory_items_fts_data
memory_items_fts_idx
opportunity_memory
pending_interactions
proposal_sources
proposals
reminders
schedules
schema_migrations
signal_candidates
signal_fps
signals
sms_conversations
sms_messages
sms_reply_drafts
source_cursors
sources
sqlite_sequence
sqlite_stat1
stream_cursors
threads
watchers
Toggle helper tables
memory_items_fts_content
memory_items_fts_docsize
memory_items_fts_segdir
memory_items_fts_segments
memory_items_fts_stat
×
Could not fetch row with primary-key sig_1fa1a62bb310.
Structure
Content
Query
Insert
Drop
Import
Export
Update row sig_f54f724798b7 in signals
id
sig_f54f724798b7
Primary key.
TEXT
event_id
128193
TEXT NOT NULL
watcher_id
NULL
TEXT
signal_type
discovery_sec_filing_delta
TEXT NOT NULL
value
{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","company":"VERTEX PHARMACEUTICALS INC / MA","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","article_chars":1701,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_434a224248b2266e","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:19:23.716531+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt","source_event_id":"evt_a4af2c737339","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"378c3ada1a5baafe","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.62,"dates_mentioned":["2026-04-17","2026-04-15","2026-04-17T03:05:05.644967+00:00"],"entities":[{"asset_class":"equity","name":"VERTEX PHARMACEUTICALS INC / MA","relevance":"high","symbol":"VRTX","type":"issuer"},{"asset_class":"person","name":"SACHS BRUCE I","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"equity","name":"Common Stock","relevance":"high","symbol":"","type":"security"}],"event_type":"listing","information_gaps":["What specifically changed vs prior known state is not provided in the signal (no prior Form 4 state or comparison data included).","The provided text does not clearly label which numeric values (107.345, 442.50, 15671.866) correspond to which Form 4 fields (e.g., number of units, transaction price, total value).","No explicit transaction type (e.g., grant, vesting, acquisition) is stated beyond the presence of \u201cDeferred Stock Units.\u201d","No guidance or financial implications for the company are explicitly disclosed in the provided text."],"key_facts":["SEC accession number: 0000875320-26-000161.","Form type: 4 (Form 4).","Conformed period of report: 20260415; filed as of date: 20260417.","Reporting owner: Bruce I. Sachs (CENTRAL INDEX KEY: 0001197036).","The filing includes \u201cDeferred Stock Units\u201d with a date shown as 2026-04-15.","The filing states: \u201cEach deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Mr. Sachs' service on our board of directors, (ii) a change of control of our company and (iii) Mr. Sachs' disability or death.\u201d","A price/amount line appears in the text: \u201c107.345\u201d and \u201c442.50\u201d and \u201c107.345 15671.866 D\u201d (exact mapping to fields is not explicitly labeled in the provided text)."],"numeric_claims":[{"label":"Price shown","value":"107.345"},{"label":"Amount shown","value":"442.50"},{"label":"Quantity shown","value":"15671.866"}],"primary_claim":"A Form 4 was filed by Vertex Pharmaceuticals (VRTX) on 2026-04-17 for reporting-owner Bruce I. Sachs, including deferred stock units tied to common stock.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Vertex Pharmaceuticals (VRTX) filed a Form 4 on 2026-04-17 covering a transaction related to deferred stock units held by Bruce I. Sachs. The filing states each deferred stock unit represents one share of common stock and is paid out in common stock upon specified triggering events.","topics":["SEC Form 4","insider/deferred stock units","common stock payout mechanics"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 VERTEX PHARMACEUTICALS INC / MA \u00b7 Filed 20260417","ticker":"VRTX","tickers":["VRTX"],"title":"VRTX filed 4","url":"https://www.sec.gov/Archives/edgar/data/875320/0000875320-26-000161.txt"}
TEXT NOT NULL
threshold
NULL
TEXT
direction
NULL
TEXT
severity
NULL
TEXT
window
NULL
TEXT
source
discovery_sec_filings
TEXT NOT NULL
reason_trace
{"_evidence_event_ids":["evt_a4af2c737339"]}
TEXT
dedupe_key
signal_enriched:discovery_sec_filing_delta:b419ee9f889f4bdd
TEXT NOT NULL
throttle_s
INTEGER (default 0
created_at
2026-04-18T03:05:05.644967+00:00
TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')
Update
Cancel